Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. MDBH
MDBH logo

MDBH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.880
Open
2.880
VWAP
2.88
Vol
425.00
Mkt Cap
29.20M
Low
2.880
Amount
1.22K
EV/EBITDA(TTM)
--
Total Shares
10.14M
EV
12.15M
EV/OCF(TTM)
--
P/S(TTM)
18.87
MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, MDB Minnesota One, Inc. Its segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment includes MDB Minnesota One, Inc., a research and development stage company that is developing a small molecule senescence platform. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.
Show More

Events Timeline

(ET)
2025-06-02
17:54:11
MDB Capital announces board transitions
select
2025-05-27 (ET)
2025-05-27
16:12:20
ClearSign Board to expand in size to seven directors
select
2025-05-21 (ET)
2025-05-21
09:04:20
MDB Capital provides Q1 update, continued to work on new opportunities
select
2025-02-21 (ET)
2025-02-21
16:07:58
eXoZymes president, chairman Hayat transitions out of roles
select

News

Newsfilter
6.5
02-26Newsfilter
Analysis of Oral Small-Molecule GLP-1 Drug Competition
  • Significant Market Potential: The injectable GLP-1 drug market has reached $71 billion but covers less than 5% of eligible patients, indicating a vast 95% market potential for oral small-molecule drugs, presenting substantial future growth opportunities.
  • Patent Portfolio Disparities: An analysis of over 1,200 patent documents reveals dramatic disparities in patent depth among programs at similar development stages, which will significantly impact their market competitiveness and long-term viability.
  • Scarcity of Partnership Opportunities: Since 2023, over $47 billion in GLP-1-related deal value has been committed, yet most oral programs remain unpartnered, highlighting potential opportunities and risks in market consolidation.
  • Importance of Patent Protection: With the patent cliffs for semaglutide and tirzepatide approaching, possessing broad patent protection will determine which assets can dominate the market and which may face early generic competition.
Newsfilter
5.0
02-03Newsfilter
MDB Capital Appoints New Board Member
  • Board Changes: MDB Capital Holdings announced the appointment of Jeb Terry to its Board of Directors while expressing gratitude to Susanne Meline for her contributions, effective February 1, 2026, reflecting the company's ongoing commitment to leadership optimization.
  • New Board Member Background: Jeb Terry brings over 20 years of investment experience in microcap medical and biotechnology sectors, having founded Aberdeen Investment Management with a focus on undervalued opportunities in life sciences, which is expected to provide MDB with valuable industry insights.
  • Strategic Implications: The addition of the new board member is seen as a crucial step for MDB in expanding its founder and investor community, with CEO Christopher Marlett emphasizing that Terry's expertise will aid the company's further development in public venture capital.
  • Future Outlook: MDB Capital remains committed to driving the growth of innovative companies through its unique public venture capital platform, focusing on early public offerings and follow-on financings to support promising enterprises.
Globenewswire
1.0
2025-12-11Globenewswire
Keiretsu Forum Hosts Successful Investor Conferences, Attracting Over 150 Investors
  • Investor Gathering: The Southeast Investor Conference and Mid-Atlantic Investor Summit attracted over 150 accredited investors and family offices, fostering in-depth discussions on early-stage capital and developing pathways for higher-quality deal flow.
  • Significant Outcomes: The Atlanta conference featured 75 investors and over 20 presentations, showcasing 10 actively funding companies, which significantly boosted investor confidence and engagement in the market.
  • Exit Strategy Optimization: The Philadelphia summit emphasized disciplined portfolio strategies and time-to-exit, proposing structured financing and 'restart' strategies to shorten exit timelines, thereby enhancing investor return expectations.
  • Future Outlook: Keiretsu Forum plans to continue its Investor Summit series in 2026, expecting to attract more local innovation-stage startups and further drive the development of the regional investment ecosystem.
Newsfilter
1.0
2025-12-11Newsfilter
Keiretsu Forum Hosts Successful Investor Conferences, Attracting Over 150 Investors
  • Investor Gathering: The Southeast Investor Conference and Mid-Atlantic Investor Summit attracted over 150 accredited investors and venture leaders, fostering a re-evaluation of early-stage capital and promoting pathways to higher-quality deal flow and liquidity.
  • Rich Conference Content: The Atlanta event featured approximately 75 investors and over 20 presentations, showcasing 10 actively funding companies, highlighting the importance of education and networking for investors.
  • Exit Strategy Optimization: The Philadelphia summit focused on accelerating exits, discussing how to extend traditional 5-7 year exit windows to 10-12 years, emphasizing the significance of disciplined portfolio strategies and capital structures.
  • Future Outlook: Keiretsu Forum plans to continue its Investor Summit series in 2026, expecting to feature more local innovation-stage startups and further enhance the regional investment ecosystem.
Newsfilter
1.0
2025-11-11Newsfilter
MDB Capital Holdings to Hold Q3 2025 Update Conference Call on Thursday, November 20, 2025, at 4:30 PM ET
  • Webinar Announcement: MDB Capital Holdings, LLC will host a Zoom webinar on November 20, 2025, at 4:30 p.m. ET to provide a business update for Q3 2025, led by CEO Christopher Marlett.

  • Access Information: Investors can pre-register for the webinar and access it through MDB's investor relations website on the day of the event.

  • Company Overview: MDB Capital, founded in 1997, focuses on launching disruptive technology companies through public venture capital, emphasizing community-driven financings and early public offerings.

  • Forward-Looking Statements: The press release includes forward-looking statements that are subject to risks and uncertainties, and MDB does not intend to update these statements after the release date.

Newsfilter
5.0
2025-09-24Newsfilter
PatentVest Appoints Dr. Sarah Cork as Senior Patent Attorney, Enhancing Leadership in Life Sciences IP
  • Dr. Sarah Cork Joins PatentVest: Dr. Sarah Cork has been appointed as a Senior Patent Attorney at PatentVest, enhancing the firm's capabilities in the life sciences sector and intellectual property strategies.

  • Expertise and Leadership: With over a decade of experience in biotechnology and pharmaceuticals, Dr. Cork specializes in complex IP matters and is actively involved in the intellectual property community, serving in leadership roles and contributing to various organizations.

Valuation Metrics

The current forward P/E ratio for MDB Capital Holdings LLC (MDBH.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess MDB Capital Holdings LLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

con rentabilidad alta a corto plazo
Intellectia · 61 candidates
Price: <= $20.00Quarter Revenue Yoy Growth: >= 20.0%Quarter Eps Yoy Growth: >= 15.0%Relative Vol: >= 1.50
Ticker
Name
Market Cap$
top bottom
RBKB logo
RBKB
Rhinebeck Bancorp Inc
134.53M
BZAI logo
BZAI
Blaize Holdings Inc
255.60M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
IBRX logo
IBRX
Immunitybio Inc
6.82B
MDBH logo
MDBH
MDB Capital Holdings LLC
33.86M

Whales Holding MDBH

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is MDB Capital Holdings LLC (MDBH) stock price today?

The current price of MDBH is 2.88 USD — it has increased 0

What is MDB Capital Holdings LLC (MDBH)'s business?

MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, MDB Minnesota One, Inc. Its segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment includes MDB Minnesota One, Inc., a research and development stage company that is developing a small molecule senescence platform. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.

What is the price predicton of MDBH Stock?

Wall Street analysts forecast MDBH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDBH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is MDB Capital Holdings LLC (MDBH)'s revenue for the last quarter?

MDB Capital Holdings LLC revenue for the last quarter amounts to 1.25M USD, decreased -303.65

What is MDB Capital Holdings LLC (MDBH)'s earnings per share (EPS) for the last quarter?

MDB Capital Holdings LLC. EPS for the last quarter amounts to -0.46 USD, decreased -44.58

How many employees does MDB Capital Holdings LLC (MDBH). have?

MDB Capital Holdings LLC (MDBH) has 16 emplpoyees as of March 12 2026.

What is MDB Capital Holdings LLC (MDBH) market cap?

Today MDBH has the market capitalization of 29.20M USD.